5th NovAliX Conference

Biophysics in Drug Discovery 2018

Developing the Synergy between Biophysics and Medicinal Chemistry to Deliver Better Drugs

 Boston, USA    June 13-15, 2018

Committees


Conference Chairman

Chairman

Dr Jean-Paul RENAUD

NovAliX & Ribostruct, Illkirch, France

Scientific Committee

Members

Prof. Michelle ARKIN

University of California, San Francisco, United States

Dr Jim BRYSON

Bristol-Myers-Squibb, Princeton, United States

Dr Bridget CARRAGHER

New York Structural Biology Center, New York, United States

Dr MariJean EGGEN

Eli Lilly, Indianapolis, United States

Dr Dan ERLANSON

Carmot Therapeutics, South San Francisco, United States

Dr Jean-Paul RENAUD

NovAliX & Ribostruct, Illkirch, France

Dr Chaohong SUN

Abbvie, North Chicago, United States

Dr Daniel WYSS

Merck, Kenilworth, United States